Travere Therapeutics (TVTX) Preferred Shares (2012)

Travere Therapeutics (TVTX) posted Preferred Shares of $1.0 for Q4 2012, little changed on a QoQ basis from $1.0 in Q1 2012.

Travere Therapeutics (TVTX) Preferred Shares (2012) Analysis & Trends

Travere Therapeutics' Preferred Shares history runs 1 years deep, the most recent figure standing at $1.0 for Q4 2012.

Quarterly Preferred Shares changed N/A year-over-year to $1.0 in Q4 2012, while the trailing twelve-month figure through Nov 2012 was $1.0 (changed N/A YoY) and the FY2012 annual result came in at $1.0, changed N/A from the prior year.
Preferred Shares was $1.0 for Q4 2012 at Travere Therapeutics, roughly flat from $1.0 in the prior quarter.
Across five years, Preferred Shares topped out at $1.0 in Q1 2012 and bottomed at $1.0 in Q1 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Travere Therapeutics	5.21 Bn	5.21 Bn	125.25 Mn	-

Download Data

Date	Value
Nov 30, 2012	1.00
Feb 29, 2012	1.00